Immune Therapeutics Announces Financing and Debt Restructuring Plan
Immune Therapeutics Announces Financing and Debt Restructuring Plan iCrowd Newswire 03 Jun 2021, 02:30 GMT+10 Orlando, Florida, June 02, 2021 — Immune Therapeutics Inc. (OTC-PINK: IMUND) (the "Company") announced today that the Company has received and signed a non-binding term sheet to enter into an agreement that would provide working capital and wipe out a significant portion of its long-standing Debt. The Company received the term sheet from existing Immune Shareholders to provide the funds necessary to complete the restructuring of Immune. According to the agreement, the investors will...